The device, called leva, and has a movement-based sensor that connects to an app to give women real-time feedback as they perform pelvic floor muscle exercises. It was approved Nov. 25.
Urinary incontinence affects an estimated 20 million women in the U.S., and early intervention has been shown to resolve or reduce symptoms and limit the need for more complex treatments, such as surgery or long term medication.
Read the full news release here.
More articles on supply chain:
Medtronic warns of potential safety risk for its insulin pumps
Birmingham hospital facing ‘dangerously low’ blood supply
Amazon develops smart shelf that automatically repurchases supplies
